Show items per page
Elements: 5
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group Joly, V.; Moroni, M.; Concia, Ercole; Lazzarin, A.; ... de Cian, W. 2000
add to browser selection
Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort Morawetz, R. A.; Rizzardi, G. P.; Glauser, Dominique; Rutschmann, Olivier Thierry; ... Pantaleo, G. 1997
add to browser selection
Low doses of zidovudine plus didanosine are less effective than higher doses of didanosine monotherapy: a randomized trial in patients pretreated with zidovudine Sudre, Philippe; Chave, J. P.; Ruef, Christian; Iten, A.; ... Hirschel, Bernard 1997
add to browser selection
A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia Hirschel, Bernard; Lazzarin, A.; Chopard, P.; Opravil, M.; ... Gabriel, V. 1991
add to browser selection
Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDS Hirschel, Bernard; Chopard, P.; Chave, J. P.; Furrer, H. J.; ... Lazzarin, A. 1990